Showing posts with label testing. Show all posts
Showing posts with label testing. Show all posts

Friday, 29 July 2016

Uptake, outcomes, and costs of implementing non-invasive prenatal testing for Down’s syndrome into NHS maternity care

"Implementation of NIPT [non-invasive prenatal testing] as a contingent test within a public sector Down’s syndrome screening programme can improve quality of care, choices for women, and overall performance within the current budget."

Uptake, outcomes, and costs of implementing non-invasive prenatal testing for Down’s syndrome into NHS maternity care: prospective cohort study in eight diverse maternity units
LS Chitty
BMJ 2016; 354 doi: http://dx.doi.org/10.1136/bmj.i3426

Read more here.

Tuesday, 16 September 2014

Societal cost-effectiveness analysis of the 21-gene assay in early-stage breast cancer in Japan

"The 21-gene assay for women with estrogen-receptor–positive, lymph-node–negative, early-stage breast cancer is projected to be cost-effective in Japan."

Societal cost-effectiveness analysis of the 21-gene assay in estrogen-receptor–positive, lymph-node–negative early-stage breast cancer in Japan
H Yamauchi et al.
BMC Health Services Research 2014, 14:372

Read more here.

Monday, 29 April 2013

Commissioning HIV testing services in England


"This toolkit is designed primarily for the many individuals and organisations who will have some responsibility for the commissioning of HIV testing services."

Commissioning HIV testing services in England: a practical guide for commissioners
National AIDS Trust
March 2013

Read more here.


Thursday, 8 March 2012

Updated guidance on the diagnosis and reporting of Clostridium Difficile

"This revised guidance to healthcare providers identifies which two types of tests, which when used in combination, will deliver the most accurate results for C. difficile infection testing."

Updated guidance on the diagnosis and reporting of Clostridium Difficile
Department of Health
March 2012

Read more here.